What is the onset and duration of action of Kenalog (triamcinolone) after intralesional injection into a scar?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Onset and Duration of Action of Kenalog (Triamcinolone) in Scar Treatment

Intralesional triamcinolone acetonide (Kenalog) begins to work within 3 days of injection into a scar, with more significant effects observed by 7 days, and typically requires 3-4 weeks between treatments for optimal results. 1, 2

Mechanism of Action and Timeline

  • Initial effects (3 days):

    • Triamcinolone begins inhibiting both type I and type III procollagen mRNA expression within 3 days of injection 2
    • Anti-inflammatory effects begin to reduce scar inflammation
  • Early visible effects (7 days):

    • By day 7, type I collagen proteins are significantly reduced (p < 0.05) 2
    • Type III collagen proteins show some reduction, though not statistically significant at this timepoint 2
    • Procollagen mRNA expression continues to decrease further by day 7 2
  • Full therapeutic effect:

    • The American Academy of Dermatology recommends treatments every 3-4 weeks until the keloid flattens 1
    • Complete flattening typically requires 4-6 treatment sessions 1

Dosing and Administration

  • Standard concentration: 40 mg/mL for most keloid treatments 1
  • Reduced concentration: 10-20 mg/mL for facial or thin-skinned areas to minimize atrophy risk 1
  • Treatment interval: Every 3-4 weeks until desired flattening is achieved 1
  • Maximum sessions: Typically 4-6 sessions are needed for optimal results 1

Factors Affecting Response Time

  1. Scar characteristics:

    • Newer scars typically respond faster than older, more established ones
    • Thinner scars generally show more rapid improvement than thicker ones
  2. Treatment combinations:

    • Combining triamcinolone with other agents may accelerate response
    • TAC combined with 5-fluorouracil (5-FU) shows faster and more effective results than TAC alone 3
    • Adding pulsed dye laser treatments simultaneously with injections appears to be most effective 4
  3. Injection frequency:

    • More frequent initial injections (once to thrice weekly) followed by decreasing frequency (weekly to monthly) during stabilization may be more efficacious 4

Common Pitfalls and Considerations

  • Avoid overtreatment: Using too high a concentration (especially in facial areas) can lead to atrophy and pigmentary changes 1
  • Monitor for side effects: Fat/dermal atrophy, pigmentary changes, and folliculitis are possible complications 1
  • Manage expectations: Inform patients that multiple treatments are typically required, with full results not immediate
  • Consider adjunctive therapy: For resistant scars, combining triamcinolone with 5-FU or laser therapy may provide superior outcomes 4, 3

For optimal results, patients should be evaluated at 3-4 week intervals to assess response and determine the need for additional treatments, with most patients requiring multiple sessions to achieve maximal scar flattening.

References

Guideline

Treatment of Keloids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Study on type I and type III procollagen mRNA and in situ collagen proteins expressions in hypertrophic scars after intralesional Kenalog treatment].

Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery, 2000

Research

Treatment of inflamed hypertrophic scars using intralesional 5-FU.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.